Compulsory Licenses. If Licensee is caused to grant a compulsory license to any Third Party with respect to a Product in any country in the Territory, then the royalty rate to be paid by Licensee on Net Sales due on such Product in that country under Section 5.1 shall be reduced to the rate paid by such Third Party compulsory licensee on such Product.
Appears in 5 contracts
Samples: License Agreement (Keryx Biopharmaceuticals Inc), License Agreement (Keryx Biopharmaceuticals Inc), License Agreement (Keryx Biopharmaceuticals Inc)
Compulsory Licenses. If Licensee is caused to grant a compulsory license is granted to any a Third Party with respect to a Product in any country in the TerritoryTerritory with a royalty rate lower than the royalty rate provided by Section 5.1.1, then the royalty rate to be paid by Licensee ACORDA on Net Sales due on such Product in that country under Section 5.1 5.1.1 shall be reduced to the rate paid by such the compulsory Third Party compulsory licensee on such Productlicensee.
Appears in 4 contracts
Samples: License Agreement (Acorda Therapeutics Inc), License Agreement (Acorda Therapeutics Inc), License Agreement (Acorda Therapeutics Inc)
Compulsory Licenses. If Licensee is caused to grant Should a compulsory license be granted to any a Third Party with respect to a Product in under the applicable laws of any country in the TerritoryTerritory under the Licensed Technology hereunder, then the royalty rate to be paid by Licensee on Net Sales due on payable hereunder for the sale of Products in such Product in that country under Section 5.1 shall be reduced by an amount equivalent to the lower royalty rate paid by granted to such Third Party compulsory licensee on for such Productcountry.
Appears in 3 contracts
Samples: Exclusive License Agreement (United Therapeutics Corp), Exclusive License Agreement (Virexx Medical Corp), Exclusive License Agreement (Altarex Corp)
Compulsory Licenses. If Licensee is caused required to grant a compulsory license to any a Third Party with respect to a Product in as required by the applicable laws of any country in the TerritoryTerritory under the Licensed Patents, and the royalty rate payable to Licensee for sales of Licensed Product by such Third Party is lower than the royalty rate payable by Licensee to Licensor for such sales, then the royalty rate to be paid payable hereunder by Licensee on Net Sales due on such Product in that country under Section 5.1 shall be reduced to the rate paid for sales of Licensed Products by such Third Party compulsory licensee on in such Productcountry shall be no greater than the rate payable by such Third Party to Licensee for such country.
Appears in 1 contract
Samples: License Agreement (Innovate Biopharmaceuticals, Inc.)